Neuropathix, Inc. (NPTX)

Number of records: 22
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
13-Jun-22 4:31 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 13-Jun-22Gift 400,000$0.02$6,440.00(2%)
23.55M to 23.15M
13-Jun-22 4:31 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 09-Jun-22Sale 238,164$0.02$5,001.44(1%)
23.8M to 23.56M
13-Jun-22 4:31 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 08-Jun-22Sale 21,836$0.02$458.56(< 1%)
23.82M to 23.8M
13-Jun-22 4:31 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 07-Jun-22Sale 50,000$0.02$1,000.00(< 1%)
23.87M to 23.82M
13-Jun-22 4:31 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 06-Jun-22Sale 10,000$0.03$250.00(< 1%)
23.88M to 23.87M
02-Jun-22 5:23 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 31-May-22Sale 30,000$0.03$800.00(< 1%)
23.91M to 23.88M
02-Jun-22 5:23 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 27-May-22Sale 50,000$0.03$1,450.00(< 1%)
23.96M to 23.91M
02-Jun-22 5:23 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 26-May-22Sale 100,000$0.03$2,600.00(< 1%)
24.06M to 23.96M
07-Jan-22 5:22 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 07-Jan-22Gift 550,000----(2%)
24.65M to 24.1M
07-Jan-22 5:22 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 07-Jan-22Sale (Planned) 41,000$0.05$1,886.00(< 1%)
24.1M to 24.06M
07-Jan-22 5:22 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 06-Jan-22Sale (Planned) 120,000$0.05$6,120.00(< 1%)
24.77M to 24.65M
07-Jan-22 5:22 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 05-Jan-22Sale (Planned) 89,000$0.05$4,183.00(< 1%)
24.86M to 24.77M
02-Aug-21 8:04 AM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 29-Jul-21Grant 1,875,000$0.05$90,000.008%
22.98M to 24.86M
16-Mar-21 4:47 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
Neuropathix, Inc. (NPTX) 12-Mar-21Grant 884,616$0.13$115,000.004%
22.71M to 23.59M
03-Dec-19 3:47 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 27-Nov-19Sale 100,000$1.00$100,000.00(< 1%)
22.19M to 22.09M
06-May-20 9:36 PM
View: 
Kinney William
Chief Scientific Officer
Neuropathix, Inc. (NPTX) 14-Aug-19Grant 200,000$0.10$20,000.0015%
1.33M to 1.53M
06-May-20 9:39 PM
View: 
Schroeder Blake
Director
Neuropathix, Inc. (NPTX) 14-Aug-19Grant 250,000$0.10$25,000.00100%
0 to 250.0K
06-May-20 9:38 PM
View: 
Malasek Robert
Director
Neuropathix, Inc. (NPTX) 14-Aug-19Grant 250,000$0.10$25,000.00100%
0 to 250.0K
06-May-20 9:45 PM
View: 
Scott Timothy Richard
Director
Neuropathix, Inc. (NPTX) 14-Aug-19Grant 250,000$0.10$25,000.00100%
0 to 250.0K
06-May-20 9:39 PM
View: 
Petkanas Dean
Chief Executive Officer
Director
10% Owner
Neuropathix, Inc. (NPTX) 14-Aug-19Grant
Duplicate
200,000$0.10$20,000.00< 1%
22.09M to 22.29M
08-Aug-18 3:51 PM
View: 
Kettner Investments, LLC
Neuropathix, Inc. (NPTX) 25-Jul-18Acquisition (other) 3,067,070----41%
7.5M to 10.57M
08-Aug-18 3:51 PM
View: 
Kettner Investments, LLC
Neuropathix, Inc. (NPTX) 25-Jul-18Sale 3,750,000----(35%)
10.57M to 6.82M